IP Library Granted Patent US 11,944,687
Granted Patent B2
US 11,944,687 · App. 17/857,531 · Granted Apr 2, 2024

Carbohydrate conjugate RNA agents and process for their preparation

Inventors: Jayaprakash K. Nair (Cambridge, MA); Alexander V Kel'in (Cambridge, MA); Pachamuthu Kandasamy (Cambridge, MA); Kallanthottathil G Rajeev (Cambridge, MA); Muthiah Manoharan (Cambridge, MA)
Assignee: ALNYLAM PHARMACEUTICALS, INC.
A61K47/549A61K31/7088C07C231/14C07D207/12C07H1/00C07H15/26C12N15/113C12N2310/351C12N2320/32
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,944,687
App. No.
17/857,531
Granted
Apr 2, 2024
Kind
B2
Abstract

This disclosure relates to an improved process for the preparation of carbohydrate conjugates. The disclosure also relates to carbohydrate conjugated iRNA agents comprising these carbohydrate conjugates, which have improved purity and are advantageous for the in vivo delivery of the iRNA agents.

Claims (25)

1. A process for preparing a compound of formula (A)

wherein

each occurrence of X is hydrogen or a hydroxy protecting group;

each occurrence of Y is an amine protecting group;

n is 0-20;

each occurrence of q, r and s is independently 1-7;

L is a linking group;

R 1 is an iRNA agent;

the compound of formula (A) contains no more than 1000 ppm of metal impurities; and

the compound of formula (A) contains no more than 0.5% by weight of each of the following two urea side products

 and

each of the following saccharide compounds

the process comprising:

(a) converting a compound of formula (VI) to a compound of formula (VII):

wherein said converting step comprises:

(i) reacting the compound of formula (VI) with a base;

(ii) reducing the product of step (i); and

(iii) reacting the product of step (ii) with an acid, and

(b) converting the compound of formula (VII) to a compound of formula (A).

2. The process of claim 1 , wherein the base is a metal alkoxide.

3. The process of claim 1 , wherein

the base is sodium methoxide,

step (ii) comprises reacting the product of step (i) with sodium borohydride, and

the acid in step (iii) is hydrochloric acid.

4. The process of claim 1 , wherein Y is acetyl.

Assignments (2)
SECURITY INTEREST Recorded Oct 1, 2025
From: ALNYLAM PHARMACEUTICALS, INC.; SIRNA THERAPEUTICS, INC.
To: BANK OF AMERICA, N.A.
Reel/Frame 072996/0337 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 13, 2024
From: NAIR, JAYAPRAKASH K; KELIN, ALEXANDER V; KANDASAMY, PACHAMUTHU; RAJEEV, KALLANTHOTTATHIL G; MANOHARAN, MUTHIAH
To: ALNYLAM PHARMACEUTICALS, INC.
Reel/Frame 066454/0659 →